VORICONAZOLE
Manner of administration:Oral
Restriction
Indication: Prophylaxis of invasive fungal infections including both yeasts and moulds
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 0 | DPMQ: $507.72 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Vfend | |||||
Manner of administration:Oral
Restriction
Indication: Prophylaxis of invasive fungal infections including both yeasts and moulds
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 56 | # of repeats: 0 | DPMQ: $48.26 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||
Manner of administration:Oral
Restriction
Indication: Prophylaxis of invasive fungal infections including both yeasts and moulds
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 56 | # of repeats: 0 | DPMQ: $153.56 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||
Manner of administration:Oral
Restriction
Indication: Definite or probable invasive aspergillosis
Treatment phase: Treatment and maintenance therapy
Restriction
Indication: Serious fungal infections
Treatment phase: Treatment and maintenance therapy
Restriction
Indication: Serious Candida infections
Treatment phase: Treatment and maintenance therapy
Restriction
Indication: Serious invasive mycosis infections
Treatment phase: Treatment and maintenance therapy
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 56 | # of repeats: 2 | DPMQ: $48.26 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||
Manner of administration:Oral
Restriction
Indication: Definite or probable invasive aspergillosis
Treatment phase: Treatment and maintenance therapy
Restriction
Indication: Serious fungal infections
Treatment phase: Treatment and maintenance therapy
Restriction
Indication: Serious Candida infections
Treatment phase: Treatment and maintenance therapy
Restriction
Indication: Serious invasive mycosis infections
Treatment phase: Treatment and maintenance therapy
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 56 | # of repeats: 2 | DPMQ: $153.56 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
|
|
|||||
|
|
|||||
|
|
|||||
Manner of administration:Oral
Restriction
Indication: Definite or probable invasive aspergillosis
Treatment phase: Treatment and maintenance therapy
Restriction
Indication: Serious fungal infections
Treatment phase: Treatment and maintenance therapy
Restriction
Indication: Serious Candida infections
Treatment phase: Treatment and maintenance therapy
Restriction
Indication: Serious invasive mycosis infections
Treatment phase: Treatment and maintenance therapy
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 0 | DPMQ: $507.72 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Vfend | |||||